Dimensional Fund Advisors
AMRI

Dimensional Fund Advisors’s Albany Molecular Research Inc AMRI Stock Holding History

Dimensional Fund Advisors’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,346,341
Closed -$29.2M – 3376
2017
Q2 		$29.2M Sell
1,346,341
-94,693
-7% -$1.72M 0.01% 1767
2017
Q1 		$20.2M Sell
1,441,034
-80,651
-5% -$1.32M 0.01% 1989
2016
Q4 		$28.5M Sell
1,521,685
-110,854
-7% -$1.88M 0.01% 1686
2016
Q3 		$27M Sell
1,632,539
-40,314
-2% -$597K 0.01% 1672
2016
Q2 		$22.5M Sell
1,672,853
-63,646
-4% -$928K 0.01% 1738
2016
Q1 		$26.6M Sell
1,736,499
-70,135
-4% -$1.1M 0.02% 1576
2015
Q4 		$35.9M Sell
1,806,634
-233,909
-11% -$4.45M 0.02% 1207
2015
Q3 		$35.5M Sell
2,040,543
-40,342
-2% -$821K 0.02% 1167
2015
Q2 		$42.1M Sell
2,080,885
-227,758
-10% -$4.4M 0.03% 1043
2015
Q1 		$40.6M Sell
2,308,643
-392,174
-15% -$6.68M 0.03% 1050
2014
Q4 		$44M Sell
2,700,817
-26,870
-1% -$493K 0.03% 885
2014
Q3 		$60.2M Buy
2,727,687
+11,442
+0.4% +$234K 0.04% 541
2014
Q2 		$54.6M Buy
2,716,245
+86,977
+3% +$1.47M 0.04% 632
2014
Q1 		$48.9M Buy
2,629,268
+4,037
+0.2% +$55.6K 0.04% 664
2013
Q4 		$26.5M Sell
2,625,231
-21,393
-0.8% -$259K 0.02% 1218
2013
Q3 		$34.1M Sell
2,646,624
-6,571
-0.2% -$80.8K 0.03% 828
2013
Q2 		$31.5M Buy
+2,653,195
New +$28.7M 0.03% 823

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Dimensional Fund Advisors's AMRI Position: Q3 2017 in Review

Dimensional Fund Advisors sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 1,346,341 shares — an estimated $29.2M sold.

Dimensional Fund Advisors first reported a position in AMRI in Q2 2013 and held it in 17 quarters. The position peaked at $60.2M in Q3 2014. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Dimensional Fund Advisors reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Dimensional Fund Advisors sold 1,346,341 Albany Molecular Research Inc shares in Q3 2017, an estimated $29.2M.
  • Dimensional Fund Advisors first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 17 quarters.
  • Dimensional Fund Advisors's Albany Molecular Research Inc position peaked at $60.2M in Q3 2014.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Dimensional Fund Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.